Tobramycin – Injection products
Recognized Interpretive Criteria
Additional FDA-identified interpretive criteria
| Minimum Inhibitory | Disk Diffusion | ||||
---|---|---|---|---|---|---|
Pathogen | S | I | R | S | I | R |
Enterobacteriaceae | M100 standard is recognized | |||||
Pseudomonas aeruginosa | M100 standard is recognized | |||||
Staphylococcus aureus | ≤ 4 | 8 | ≥ 16 | ≥ 15 | 13-14 | ≤ 12 |
S = Susceptible; I = Intermediate; R = Resistant
Exceptions to the recognized standard of CLSI M100
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Acinetobacter spp.
Other Non-Enterobacteriaceae